Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-03-27
2011-10-18
Cook, Lisa (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C436S001000, C436S501000, C436S518000, C424S009100, C424S520000, C422S050000, C530S300000, C530S350000
Reexamination Certificate
active
08039222
ABSTRACT:
A method for the treatment or prevention of tissue damage in a subject having an inflammatory and/or tissue damaging condition, which comprises administering to the subject an effective amount of a compound capable of inhibiting the binding of C-reactive protein (CRP) to an autologous or extrinsic ligand.
REFERENCES:
patent: 4640913 (1987-02-01), Wissner et al.
patent: 5064817 (1991-11-01), Yedgar et al.
patent: 5681829 (1997-10-01), Tempesta et al.
patent: 5811568 (1998-09-01), Bierer et al.
patent: 6764826 (2004-07-01), Yeh et al.
patent: WO 01/94951 (2001-12-01), None
patent: WO 03/013508 (2003-02-01), None
Wang et al., “Synthesis and Properties of a Bipolar, Bisphosphatidyl Ethanolamine That Forms Stable 2-Dimensional Self-Assembled Bilayer Systems and Liposomes,” J. Org. Chem., American Chemical Society, p. 4140-4147, (May 4, 1999).
Lu et al., “Synthetic Analogues of Irlbacholine: A Novel Antifungal Plant Metabolite isolated from Irlbachia Alata,” J. Nat. Prod., American Chemical Society and American Society of Pharmacognosy, p. 824-828, (May 19, 1999).
Bhakdi et al., “Possible Protective Role for C-Reactive Protein in Atherogenesis,” Circulation, p. 1870-1876, ( 2004a).
Bhakdi et al., “Beyond cholesterol: the enigma of atherosclerosis revisited,” Thromb. Haemost., p. 639-645, ( 2004b).
Vadas et al., “Inhibition of human group II phospholipase A2 by C-reactive protein in vitro,” J. Lipid Mediat. Cell Signal, vol. 11 ( No. 2), p. 187-200 (abstract only), ( 1995).
Tsujimoto et al., “C-Reactive protein induced agglutination of lipid suspensions prepared in the presence and absence of phosphatidylcholine,” J. Biochem., vol. 87 ( No. 5), p. 1531-7 (abstract only), (1980).
Mori et al., “Involvements of fibronectin and lysophosphatidylcholine for selective binding of c-reactive protein,” Cell Mol Biol., vol. 37 ( No. 4), p. 421-31 (abstract only), ( 1991).
Chang et al., “C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids,” Proc. Natl. Acad. Sci. U.S.A., vol. 99 ( No. 20), p. 13043-8, ( 2002).
Gill et al., “Human C-Reactive Protein Increases Cerebral Infarct Size After Middle Cerebral Artery Occlusion in Adult Rats,” J. Cerebral Blood Flow & Metabolism, vol. 24 ( No. 11), p. 1214-1218, (Nov. 2004).
Berman et al., “Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis,” J. Immunol., 1986, 136(4):1354-9.
Mold et al., “Regulation of complement activation by C-reactive protein,” Immunopharmacology, 1999, 42:23-30.
Pepys, M.B. and Baltz, M.L. (1983) Acute phase proteins with special reference to C-reactive protein and related protein (pentaxins) and serum amyloid A protein.Adv. Immunol., 34: 141-212.
Pepys, M.B. (1996) The acute phase response and C-reactive protein. In:Oxford Textbook of Medicine, Third Ed., vol. 2 (Weatherall, D.J., Ledingham, J.G.G. and Worrell, D.A., eds.), Oxford University Press, Oxford, pp. 1527-1533.
Volanakis, J.E. and Kaplan, M.H. (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.Proc. Soc. Exp. Biol. Med, 136: 612-614.
de Beer, F.C., Soutar, A.K., Baltz, M.L., Trayner, I., Feinstein, A. and Pepys, M.B. (1982) Low density and very low density lipoproteins are selectively bound by aggregated C-reactive protein.J. Exp. Med, 156: 230-242.
Pepys, M.B., Rowe, I.F. And Baltz, M,L. (1985) C-reactive protein: binding to lipids and lipoproteins.Int. Rev. Exp. Pathol., 27: 83-111.
Narkates, A.J. and Volanakis, J.E. (1982) C-reactive protein binding specificities: artificial and natural phospholipid bilayers.Ann. N. Y. Acad. Sci., 389: 172-182.
Volanakis, J.E. and Wirtz, K.W.A. (1979) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers.Nature, 281: 155-157.
Du Clos, T.W. (1989) C-reactive protein reacts with the U1 small nuclear ribonucleoprotein.J. Immunol., 143: 2553-2559.
Pepys, M.B., Booth, S.E., Tennent, G.A., Butler, P.J.G. and Williams, D.G. (1994) Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.Clin. Exp. Immunol., 97: 152-157.
Kindmark, C.-O. (1972) In vitro binding of human C-reactive protein by some bacteria and zymosan.Clin. Exp. Immunol., 11: 283-289.
Fletcher, T.C., White, A. and Baldo, B.A. (1980) Isolation of a phosphorylcholine-containing component from the turbot tapeworm,Bothriocephalus scorpii(Muller) and its reaction with C-reactive protein.Parasite Immunol., 2: 237-248.
de Beaufort, A.J., Langermans, J.A.M., Matze-van der Lans, A.M., Hiemstra, P.S., Vossen, J.M. and Van Furth, R. (1997) Difference in binding of killed and liveStreptococcus pneumoniaeserotypes by C-reactive protein.Scand. J. Immunol., 46: 597-600.
Weiser, J.N., Pan, N., McGowan, K.L., Musher, D., Martin, A. and Richards, J. (1998) Phosphorylcholine on the lipopolysaccharide ofHaemophilus influenzaecontributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein.J. Exp. Med, 187: 631-640.
Culley, F.J., Bodman-Smith, K.B., Ferguson, M.A.J., Nikolaev, AN., Shantilal, N. and Raynes, J.G. (2000) C-reactive protein binds to phosphorylated carbohydrates.Glycobiology, 10: 59-65.
Kaplan, M.H. and Volanakis, J.E. (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.J. Immunol., 112: 2135-2147.
Volanakis, J.E. and Kaplan, M.H. (1974) Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea-pig complement by CRP complexes: requirement for human Clq.J. Immunol., 113: 9-17.
Claus, D.R., Siegel, J., Petras, K., Osmand, A.P. and Gewurz, H. (1977) Interactions of C-reactive protein with the first component of human complement.J. Immunol., 119: 187-192.
Volanakis, J.E. (1982) Complement activation by C-reactive protein complexes.Ann. N. Y. Acad Sci., 389: 235-250.
Mortensen, R.F., Osmand, A.P., Lint, T.F. and Gewurz, H. (1976) Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.J. Immunol., 117: 774-781.
Nakayama, S., Mold, C., Gewurz, H. and Du Clos, T.W. (1982) Opsonic properties of C-reactive protein in vivo.J. Immunol., 128: 2435-2438.
Osmand, A.P., Mortensen, R.F., Siegel, J. and Gewurz, H. (1975) Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP.J. Exp. Med, 142: 1065-1077.
Finland, M. and Dowling, H.F. (1935) Cutaneous reactions and antibody response to intracutaneous injections of pneumococcus polysaccharides.J. ImmunoL, 29: 285-299.
Kushner, 1. and Kaplan, M.H. (1961) Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions.J. Exp. Med, 114: 961-973.
Kushner, I., Rakita, L. and Kaplan, M.H. (1963) Studies of acute phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits.J. Clin. Invest., 42: 286-292.
Gitlin, J.D., Gitlin, J.1. And Gitlin, D. (1977) Localisation of C-reactive protein in synovium of patients with rheumatoid arthritis.Arthritis Rheum., 20: 1491-1499.
Du Clos, T.W., Mold, C., Paterson, P.Y., Alroy, J. and Gewurz, H. (1981) Localization of C-reactive protein in inflammatory lesions of experimental allergic encephalomyelitis.Clin. Exp. Immunol., 43: 565-573.
Lagrand, W.K., Niessen, H.W.M., Wolbink, G-J., Jaspars, L.H., Visser, C.A., Verheugt, F.W.A., Meijer, C.J.L.M. and Hack, C.E. (1997) C-reactive protein colocalizes with complement in human hearts during acute myocardia
Cook Lisa
Kiselgof Eugenia
Kowalski Thomas J.
Pentraxin Therapeutics Limited
Vedder Price P.C.
LandOfFree
Treatment and prevention of tissue damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and prevention of tissue damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prevention of tissue damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289754